Literature DB >> 22259058

Heart failure is a clinically and densitometrically independent risk factor for osteoporotic fractures: population-based cohort study of 45,509 subjects.

Sumit R Majumdar1, Justin A Ezekowitz, Lisa M Lix, William D Leslie.   

Abstract

OBJECTIVE: The aim of the study was to determine whether heart failure is associated with an increased risk of major osteoporotic fractures that is independent of bone mineral density (BMD).
METHODS: We conducted a population-based cohort study in Manitoba, Canada, by linking a clinical registry of all adults 50 yr of age and older who underwent initial BMD testing from 1998-2009 with administrative databases. We collected osteoporosis risk factors, comorbidities, medications, and BMD results. Validated algorithms identified recent-onset heart failure before the BMD test and new fractures after. The main outcome was time to major osteoporotic fractures (i.e. clinical vertebrae, distal forearm, humerus, and hip), and multivariable proportional hazards models were used for analyses.
RESULTS: The cohort consisted of 45,509 adults; 1,841 (4%) had recent-onset heart failure. Subjects with heart failure were significantly (P < 0.001) older (74 vs. 66 yr) and had more previous fractures (21 vs. 13%) and lower total hip BMD [T-score, -1.3 (sd 1.3) vs. -0.9 (sd 1.2)] than those without. There were 2703 incident fractures over the 5-yr observation. Overall, 10% of heart failure subjects had incident major fractures compared with 5% of those without [unadjusted hazard ratio (HR), 2.45; 95% confidence interval (CI), 2.11-2.85]. Adjustment for osteoporosis risk factors, comorbidities, and medications attenuated but did not eliminate this association (HR, 1.33; 95% CI, 1.11-1.60), nor did further adjustment for total hip BMD (HR, 1.28; 95% CI, 1.06-1.53).
CONCLUSIONS: Heart failure is associated with a 30% increase in major fractures that is independent of traditional risk factors and BMD, and it also identifies a high-risk population that may benefit from increased screening and treatment for osteoporosis.

Entities:  

Mesh:

Year:  2012        PMID: 22259058     DOI: 10.1210/jc.2011-3055

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Ischemic heart disease is associated with lower cortical volumetric bone mineral density of distal radius.

Authors:  J Paccou; M H Edwards; K A Ward; K A Jameson; C L Moss; N C Harvey; E M Dennison; C Cooper
Journal:  Osteoporos Int       Date:  2015-04-24       Impact factor: 4.507

2.  β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects.

Authors:  K A Toulis; K Hemming; S Stergianos; K Nirantharakumar; J P Bilezikian
Journal:  Osteoporos Int       Date:  2013-10-10       Impact factor: 4.507

Review 3.  Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.

Authors:  Mahua Ghosh; Sumit R Majumdar
Journal:  Endocrine       Date:  2014-02-07       Impact factor: 3.633

4.  Association between cardiovascular diseases and osteoporosis-reappraisal.

Authors:  Pawel Szulc
Journal:  Bonekey Rep       Date:  2012-08-08

5.  Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.

Authors:  J-C Youn; S J Lee; H S Lee; J Oh; N Hong; S Park; S-H Lee; D Choi; Y Rhee; S-M Kang
Journal:  Osteoporos Int       Date:  2015-05-12       Impact factor: 4.507

6.  A prospective assessment of cardiac biomarkers for hemodynamic stress and necrosis and the risk of falls among older people: the ActiFE study.

Authors:  Dhayana Dallmeier; Jochen Klenk; Raphael S Peter; Michael Denkinger; Richard Peter; Kilian Rapp; Wolfgang Koenig; Dietrich Rothenbacher
Journal:  Eur J Epidemiol       Date:  2015-07-01       Impact factor: 8.082

7.  Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation.

Authors:  Christina Wu; Tomoko S Kato; Katherine Pronschinske; Sylvia Qiu; Yoshifumi Naka; Hiroo Takayama; Ulrike Schulze-Späte; Serge Cremers; Elizabeth Shane; Donna Mancini; P Christian Schulze
Journal:  Eur J Heart Fail       Date:  2012-09-18       Impact factor: 15.534

8.  Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study.

Authors:  S R Majumdar; S N Morin; L M Lix; W D Leslie
Journal:  Osteoporos Int       Date:  2013-04-10       Impact factor: 4.507

Review 9.  Recent advances: osteoporosis in the "oldest old".

Authors:  Cathleen S Colón-Emeric
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

10.  Prospective evaluation of renal function, serum vitamin D level, and risk of fall and fracture in community-dwelling elderly subjects.

Authors:  D Rothenbacher; J Klenk; M D Denkinger; F Herbolsheimer; T Nikolaus; R Peter; B O Boehm; K Rapp; D Dallmeier; W Koenig
Journal:  Osteoporos Int       Date:  2013-11-13       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.